Pharmaceutical Contract Manufacturing Organization Market

Latin America Pharmaceutical Contract Manufacturing Organization Market by Service Types (Development & Manufacturing [Injectable Dose Formulation, Solid Dose Formulation, and Liquid Dose Formulation], Secondary Packaging, and Active Pharmaceutical Ingredient Manufacturing [High Potency API{HPAPI}, Small Molecules, and Large Molecules]), End-users (Healthcare Providers and Healthcare Payers), and Regions (Latin America)–Industry Analysis, Growth, Shares, Size, Trends, and Forecast 2021¬–2028

  • Report ID: HC-1762
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 185
  • Format:
  • Pub. Date: Upcoming
  • Share:

The Latin America pharmaceutical contract manufacturing organization market size is anticipated to expand at a significant CAGR during the forecast period 2021–2028. Growth of the market is attributed to rising healthcare expenditure, increasing demand for cost control in drug development, and rising investments in pharmaceutical for research & development.

Latin America Pharmaceutical Contract Manufacturing Organization Market key takeaways

Contract manufacturing organization is a corporation that assists other companies in the pharmaceutical sector on a contract basis to provide broad services from drug manufacturing through drug development. This permits major pharmaceutical players to overcome those phases of the business.

The Covid-19 pandemic affected the demand and supply of Latin America pharmaceutical contract manufacturing organization market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing access to advanced technologies is projected to boost the market.
  • Rising demand for biological therapies is the major factor fueling the market.
  • Lack of manufacturing standardization is projected to restrict the market expansion during the forecast period.
  • High price of services is anticipated to hamper the market growth in the coming years.
  • R&D investment and technological advancement in pharmaceutical contract manufacturing organization market is projected to offer lucrative opportunities for the market players.

Scope of the Report

The report on the Latin America pharmaceutical contract manufacturing organization market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Latin America Pharmaceutical Contract Manufacturing Organization Market – Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018-2019

Forecast Period

2021-2028

Segmentation

Service Types [Finished Dosage Formulation Development & Manufacturing (Injectable Dose Formulation, Solid Dose Formulation, and Liquid Dose Formulation), Secondary Packaging, and Active Pharmaceutical Ingredient Manufacturing(High Potency API[HPAPI], Small Molecules, and Large Molecules)], End-users [Healthcare Providers and Healthcare Payers]

Geographical Scope

Ecuador, Colombia, Mexico, Chile, Argentina, Brazil, and Rest of the Latin America

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players covered in the Report

Lonza Group; Pfizer CentreSource [Pfizer Inc]; Boehringer Ingelheim Group; Jubilant Life Sciences Ltd.; Recipharm AB; Famer SA; Aenova Group; Baxter Biopharma Solutions [Baxter International Inc.]; Thermo Fisher Scientific Inc.[Patheon Inc.]; and Catalent Inc.

 

Market Segment Insights

The finished dosage formulation development & manufacturing accounts for a key share of the market

Based on service types, the Latin America pharmaceutical contract manufacturing organization market is fragmented into finished dosage formulation development & manufacturing, secondary packaging, and active pharmaceutical ingredient manufacturing. The finished dosage formulation development and manufacturing segment is sub-segmented into injectable dose formulation, solid dose formulation, and liquid dose formulation. The active pharmaceutical ingredient manufacturing segment is sub-segmented into high potency API [HPAPI], small molecules, and large molecules. The finished dosage formulation development & manufacturing accounts for a key share of the market. Growth of the market is attributed to growing focus on specialty medicines and rapid growth in the nuclear medicines sector. However, the active pharmaceutical ingredient manufacturing segment is anticipated to expand at a rapid pace during the forecast period due to factors such as advancement in cell & gene therapies, growing number of cell therapy candidates, and rapid progression through the various phases.

The healthcare payers accounts for a key share of the market

Based on end-users, the market is divided into healthcare providers and healthcare payers. The healthcare payers accounts for a key share of the market. Growth of the market is attributed to increasing demand for facilities that offer manufacturing services, high demand for end-to-end services in big pharmaceuticals, and growing demand for biosimilar and vaccines. However, the healthcare providers are anticipated to expand at a rapid pace during the forecast period due to factors such as growing need to streamline execution costs, increasing number of clinical trials, and presence of leading pharmaceutical companies.

Latin America Pharmaceutical Contract Manufacturing Organization Market by End Users

Brazil is anticipated to hold significant market share

On the basis of region, the Latin America pharmaceutical contract manufacturing organization market is categorized as Ecuador, Colombia, Mexico, Chile, Argentina, Brazil, and Rest of the Latin America. The market of Mexico is estimated to expand at a high CAGR during the forecast period due to growing demand for generic medicines, growth in scientific curiosity in the medicinal areas, and innovation of new drugs to fight against high-potency diseases. The market of Brazil is estimated to hold significant market share due to regulatory approval of the drug, increasing demand for next-generation biological therapies, and growing government initiatives in healthcare sector.

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pharmaceutical Contract Manufacturing Organization Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Pharmaceutical Contract Manufacturing Organization Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Pharmaceutical Contract Manufacturing Organization Market - Supply Chain
  4.5. Global Pharmaceutical Contract Manufacturing Organization Market Forecast
     4.5.1. Pharmaceutical Contract Manufacturing Organization Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Pharmaceutical Contract Manufacturing Organization Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Pharmaceutical Contract Manufacturing Organization Market Absolute $ Opportunity
5. Global Pharmaceutical Contract Manufacturing Organization Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Pharmaceutical Contract Manufacturing Organization Market Size and Volume Forecast by End Users
     5.3.1. Healthcare Providers
     5.3.2. Healthcare Payers
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Pharmaceutical Contract Manufacturing Organization Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Pharmaceutical Contract Manufacturing Organization Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Pharmaceutical Contract Manufacturing Organization Demand Share Forecast, 2019-2026
7. North America Pharmaceutical Contract Manufacturing Organization Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Pharmaceutical Contract Manufacturing Organization Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Pharmaceutical Contract Manufacturing Organization Market Size and Volume Forecast by End Users
     7.4.1. Healthcare Providers
     7.4.2. Healthcare Payers
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Pharmaceutical Contract Manufacturing Organization Demand Share Forecast, 2019-2026
8. Latin America Pharmaceutical Contract Manufacturing Organization Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Pharmaceutical Contract Manufacturing Organization Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Pharmaceutical Contract Manufacturing Organization Market Size and Volume Forecast by End Users
     8.4.1. Healthcare Providers
     8.4.2. Healthcare Payers
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Pharmaceutical Contract Manufacturing Organization Demand Share Forecast, 2019-2026
9. Europe Pharmaceutical Contract Manufacturing Organization Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Pharmaceutical Contract Manufacturing Organization Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Pharmaceutical Contract Manufacturing Organization Market Size and Volume Forecast by End Users
     9.4.1. Healthcare Providers
     9.4.2. Healthcare Payers
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Pharmaceutical Contract Manufacturing Organization Demand Share Forecast, 2019-2026
10. Asia Pacific Pharmaceutical Contract Manufacturing Organization Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Pharmaceutical Contract Manufacturing Organization Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Pharmaceutical Contract Manufacturing Organization Market Size and Volume Forecast by End Users
     10.4.1. Healthcare Providers
     10.4.2. Healthcare Payers
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Pharmaceutical Contract Manufacturing Organization Demand Share Forecast, 2019-2026
11. Middle East & Africa Pharmaceutical Contract Manufacturing Organization Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Pharmaceutical Contract Manufacturing Organization Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Pharmaceutical Contract Manufacturing Organization Market Size and Volume Forecast by End Users
     11.4.1. Healthcare Providers
     11.4.2. Healthcare Payers
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Pharmaceutical Contract Manufacturing Organization Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Pharmaceutical Contract Manufacturing Organization Market: Market Share Analysis
  12.2. Pharmaceutical Contract Manufacturing Organization Distributors and Customers
  12.3. Pharmaceutical Contract Manufacturing Organization Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Lonza Group
     12.4.2. Pfizer CentreSource [Pfizer Inc]
     12.4.3. Boehringer Ingelheim Group
     12.4.4. Jubilant Life Sciences Ltd.
     12.4.5. Recipharm AB
     12.4.6. Famer SA
     12.4.7. Aenova Group

Segments Covered in the Report
The Latin America pharmaceutical contract manufacturing organization market has been segmented on the basis of

Service Types

  • Development and Manufacturing
    • Injectable Dose Formulation
    • Solid Dose Formulation
    • Liquid Dose Formulation
  • Secondary Packaging
  • Active Pharmaceutical Ingredient Manufacturing
    • High Potency API[HPAPI]
    • Small Molecules
    • Large Molecules

End-users

  • Healthcare Providers
  • Healthcare Payers

Geography

  • Latin America

Key Players

  • Lonza Group
  • Pfizer CentreSource [Pfizer Inc]
  • Boehringer Ingelheim Group
  • Jubilant Life Sciences Ltd.
  • Recipharm AB
  • Famer SA
  • Aenova Group
  • Baxter Biopharma Solutions [Baxter International Inc.]
  • Thermo Fisher Scientific Inc. [Patheon Inc.]
  • Catalent Inc.

Key players competing in the Latin America pharmaceutical contract manufacturing organization market include Lonza Group; Pfizer CentreSource [Pfizer Inc]; Boehringer Ingelheim Group; Jubilant Life Sciences Ltd.; Recipharm AB; Famer SA; Aenova Group; Baxter Biopharma Solutions [Baxter International Inc.]; Thermo Fisher Scientific Inc.[Patheon Inc.]; and Catalent Inc.

Some of these players are using several market strategies such as capacity expansion, product launches, merger, partnerships, collaborations, and acquisitions to enhance their market shares and raise their production line of the business in the coming years.

Latin America Pharmaceutical Contract Manufacturing Organization Market by key players

Buy Report